Connor, Clark & Lunn Investment Management Ltd.
Position in AKBA — Akebia Therapeutics, Inc.
CIK 1596800
VANCOUVER, A1
Position in AKBA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$381,459
-$832,329 QoQ
Shares Held
274,431
-63.6% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $123,963,967 across 16 Drug Manufacturers - Specialty & Generic names. AKBA ranks #13 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
649,629 | $31,279,636 | |
| 2 | ZTS |
Zoetis Inc.
|
187,329 | $22,144,161 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
153,755 | $20,255,683 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
471,891 | $14,213,356 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
868,325 | $12,069,717 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
1,835,424 | $6,442,338 | |
| 7 | EBS |
Emergent BioSolutions Inc.
|
648,377 | $5,381,529 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
382,976 | $5,304,217 |
All Filings in AKBA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $381,459 | 274,431 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,213,788 | 753,906 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,786,423 | 1,020,668 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,297,962 | 1,180,759 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,862,081 | 969,834 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,951,102 | 1,026,896 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,381,632 | 1,046,691 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $1,066,980 | 1,046,059 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,911,381 | 1,044,471 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $769,195 | 620,319 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $711,521 | 624,142 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $562,613 | 614,878 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $169,667 | 302,977 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $69,270 | 120,053 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $161,192 | 510,102 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $80,049 | 226,770 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $338,666 | 471,681 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $909,460 | 402,416 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,240,332 | 430,671 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $800,789 | 211,290 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $306,873 | 90,657 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||